Furthermore, the frequency of circulating CD14+CD169+CD206+ monocytes in total circulating CD14+CD169+ monocytes from CRC patients was also significantly higher than that in HC (3.35% vs. 0.82%, P<0.0001; Fig 1E). This evidence concerns the gene SIGLEC1 and colorectal carcinoma.